Exact Sciences leads structurally, with growth as the clearest single gap between the two profiles. Ionis Pharmaceuticals still leads on profitability and stability, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.
The comparison is based on similar long-term financial trajectories, not sector labels.
Most of the separation is still concentrated in growth.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The clearest structural overlap shows up in margin trend and revenue growth trajectory.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
Exact Sciences Corp still looks stronger overall, though current pricing looks more supportive for Ionis Pharmaceuticals, Inc..
Valuation position uses Forward P/E and peer-relative valuation score where available.
One company is still expanding while the other is contracting, which creates a very wide growth split.
Ionis Pharmaceuticals, Inc. still looks less cycle-sensitive — that keeps the result from looking completely one-sided.
The page question resolves through growth, but stability still keeps the overall picture from reading as one-sided.
Break down the EXAS vs IONS comparison across all dimensions with the full interactive tool.
Explore how EXAS and IONS each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.